DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 aug 2013 - 07:21
Statutaire naam
DSM B.V.
Titel
DSM delivers higher profits; full year outlook unchanged
Bericht
DSM records 19% higher Q2 EBITDA versus Q2 2012 (€345 million versus €290 million)
Nutrition EBITDA up 28% versus Q2 2012 driven by acquisitions and organic growth
Materials Sciences continues to deliver a solid performance
Q2 cash flow from operating activities €231 million, higher than Q2 2012 and Q1 2013
Core earnings per share Q2 2013 up 28% compared to Q2 2012
Interim dividend of €0.50, in line with DSM's dividend policy
Outlook 2013 unchanged, moving towards EBITDA of €1.4 billion
Datum laatste update: 03 januari 2026